Skip to content

Sayali Tadwalkar

2 papers in the library · 39 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

An international Delphi consensus for reporting of setting in psychedelic clinical trials.

Nature Medicine June 3, 2025 Chloé Pronovost-Morgan, Kyle T. Greenway, Leor Roseman et al. 26 citations

Psychedelic substances exhibit complex interactions with the 'set and setting' of use, that is, the mental state of the user and the environment in which a psychedelic experience takes place. Despite these contextual variables' known importance, psychedelic research has lacked methodological rigor in reporting extra-pharmacological factors. This study aimed to generate consensus-based...

DOI: 10.1038/s41591-025-03685-9 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Therapeutic protocols Clinical guidelines Mental health treatment +1

Psilocybin mushrooms for psychological and existential distress

Canadian Family Physician November 1, 2022 Ryan Patchett-Marble, Sean O’sullivan, Sayali Tadwalkar et al. 13 citations

Psychedelic medicine is currently undergoing a renaissance, with interest in the medical use of these compounds exploding after decades of dormancy.[1][1] This has occurred primarily under the purview of medical researchers; however, recent legal precedents in Canada have allowed some access to